Concepedia

Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial

Scott D. Solomon, Adel R. Rizkala, Martin Lefkowitz, Victor Shi, Jianjian Gong, Nagesh S. Anavekar, Stefan D. Anker, Juan Luis Arango, J. Arenas, Dan Atar,

Circulation Heart Failure · 2018 · 147 citations · 10 references

DOIFull text

Open access

Abstract

URL: https://www.clinicaltrials.gov. Unique identifier: NCT01920711.

References

10

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

John J.V. McMurray, Milton Packer, Akshay S. Desai et al. · New England Journal of Medicine · 2014 · 6.6K citations · Full text

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Salim Yusuf, Marc A. Pfeffer, Karl Swedberg et al. · The Lancet · 2003 · 2.9K citations

, , +7

Spironolactone for Heart Failure with Preserved Ejection Fraction

Bertram Pitt, Marc A. Pfeffer, Susan F. Assmann et al. · New England Journal of Medicine · 2014 · 2.6K citations · Full text

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

Barry M. Massie, Peter E. Carson, John J.V. McMurray et al. · New England Journal of Medicine · 2008 · 1.9K citations · Full text

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

John G.F. Cleland · European Heart Journal · 2006 · 1.5K citations